Adeline Oursler

Investor type:
Locations:

Social media:

Available after registration.

Past investments

  • Goldfinch Biopharma
  • Notch Therapeutics
  • Magenta Therapeutics
  • Syros Pharmaceuticals
  • Constellation Pharmaceuticals
  • Jounce Therapeutics
  • Kallyope
  • AbSci
  • DNA Script
  • Generation Bio
  • Editas Medicine
  • MOMA Therapeutics
  • Relay Therapeutics
  • Century Therapeutics
  • Decibel Therapeutics
  • Alector
  • Orchard Therapeutics
  • Codexis
  • CytomX Therapeutics
  • Scorpion Therapeutics
  • iVexSol
  • Vividion Therapeutics
  • Paige
  • Invetx
  • Imagen Technologies
  • Verve Therapeutics
  • Prominex
  • Cerevance
  • SomaLogic
  • Arzeda
  • Earli
  • Codiak Biosciences
  • Fulcrum Therapeutics
  • Maze Therapeutics
  • Sexton Biotechnologies
  • Neon Therapeutics
  • 23andMe
  • Genome Medical
  • MyoKardia
  • Leyden Labs
  • Thrive Earlier Detection
  • Genomatica
  • Celsius Therapeutics
  • Tenaya Therapeutics
  • Cedilla Therapeutics
  • NiKang Therapeutics
  • ORIC Pharmaceuticals
  • CANbridge Pharmaceuticals
  • Auron Therapeutics
  • Verana Health
  • 4D Molecular Therapeutics
  • EQRx
  • Taysha Gene Therapies
  • Komodo Health
  • Amunix
  • Kronos Bio
  • Lyra Health
  • C2i Genomics
  • A2 Biotherapeutics
  • Monte Rosa Therapeutics
  • Pipeline Therapeutics
  • Insitro
  • Foghorn Therapeutics
  • Clover Health
  • Octave Bioscience
  • Recursion Pharmaceuticals
  • Gritstone Oncology
  • Flatiron Health
  • Revolution Medicines
  • Variant Bio
  • LianBio
  • Faze Medicines
  • PACT Pharma
  • 908 Devices
  • Beam Therapeutics
  • Vineti
  • ONI
  • Tango Therapeutics
  • Fog Pharmaceuticals